University of Ioannina
Αντιμετώπιση των νοσημάτων του παγκρέατος και των χοληφόρων με την ενδοσκοπική παλίνδρομη χολαγγειοπαγκρεατογραφία και παθοφυσιολογικές μεταβολές που συνοδεύουν την εξέταση
Abstract
dc:descriptionERCP has a crucial role in the management of hepatobiliary and pancreatic diseases. It is a widely implemented technique, yet, despite the significant technical progress achieved with regards to its safety, it remains the endoscopic technique carrying the highest complication rates. The main complication of ERCP is pancreatitis. This makes post-ERCP pancreatitis an appealing model of pancreatitis in humans, since it enables the study of the early phases of all the phenomena taking place in an acute pancreatitis attach. This research effort had a dual objective. The first was to investigate the incidence of complications in our study population of patients having ERCP and assess the role of known risk factors for the various complications. Concurrently, the role of other factors in increasing the risk of complications was investigated. Specific attention was paid to the role of medications associated to inducing pancreatitis as potential risk factors for post-ERCP pancreatitis. The second objective of this study was to assess the early changes of soluble IFN-γ, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, TNF-α, TNF-β, IL-17A , IL-22, soluble (s) P-Selectin, sE-Selectin and sICAM-1 in post-ERCP pancreatitis. This was a prospective study of ERCP procedures and an extensive number of patient characteristics as well as technical details, interventions and medications were documented. All complications were recorded and their severity assessed. The association of each potential risk factor with the various complications was investigated with univariable analyses. Those statistically significant were entered in a multivariable regression model. For the second part of the study, all patients had blood samples taken prior to the procedure as well as at 6 and 24 hours after ERCP. Those were tested for routine markers like amylase, AST, ALT, Bilirubin, ALP and γGT and serum samples were also kept in deep freeze for further analysis. The prognostic potential of various routine markers with regards to post-ERCP pancreatitis was assessed. Stored samples were used to measure the levels of the previously mentioned biomolecules. In particular, Enzyme-linked immunosorbent assay (ELISA) was used to measure adhesion molecules and flow cytometry using the FlowCytomix system was used to measure the various cytokines. Due to logistics restrictions, not all of the available samples were measured. All samples from patients with pancreatitis were measured and for each of those patients, another patient having ERCP but without post-ERCP pancreatitis was used as control. Those controls were randomly chosen and matched for age, gender and approximate period in which the procedure took place, using a predefined algorithm.A total of 318 ERCP procedures were studied. Pancreatitis occurred in 28 (8.8%) of them while haemorrhage in 7 (2.2%) and cholangitis in 5 (1.6%). With regards to pancreatitis, 4 factors were found to be statistically significant in the univariable analysis (choledocholithiasis as an indication for ERCP, stone extraction, use of medication belonging to classes I or II of the Badalov et al. classification and multiple insertions of the guidewire in the pancreatic duct). Those potential risk factors were entered in the multivariable analysis and of those, the latter 3 were found to be independently associated with the development of post-ERCP pancreatitis. In detail, the use of class I or II medications and multiple insertions (>1) of guide wire in the pancreatic duct were associated with an increase of the risk for post-ERCP pancreatitis (OR: 4.39, 95% confidence interval (CI): 1.70-5.47, p=0.003 and OR: 5.00, 95% CI: 1.97-12.81, p=0.001 respectively), while stone extraction was associated with a decrease of the risk (OR: 0.12, CI: 0.05-0.32, p<0.001). With regards to haemorrhage and cholangitis, there were too few cases to construct a multivariable model. Certain factors were found to increase the risk of haemorrhage but none of them remained statistically significant after Bonferroni correction. No risk factors were found regarding cholangitis.Amylase was the only routine marker found to be useful with regards to post-ERCP pancreatitis prognosis at 6 hours after the procedure. A level of 171 U/L was found to be the optimal cut off having a sensitivity of 92.9%, specificity of 62.4%, positive predictive value of 19.4% and negative predictive value of 98.9%.Except for significantly higher IL-1β levels in controls at baseline, no significant differences were observed between cases and controls after Bonferroni corrections. An increase in IL-6 was noted between baseline and 6h in cases alone (corrected p=0.016). There was a significant fall in sP-selectin levels at 6 and 24 hours compared to baseline in all patients (corrected p=0.008 and 0.016 for cases and 0.016 and 0.048 for controls respectively). A small, but statistically significant increase of sE-selectin in cases was observed between 6 and 24 hours post-ERCP (corrected p=0.03).This study confirmed the increased risk of post-ERCP pancreatitis carried by multiple guidewire insertions in the pancreatic duct and also detected an increased risk for the same complication related to the use of medications included in classes I or II of the Badalov et al. classification. The removal of bile-duct stones had a protective effect with regards to post-ERCP pancreatitis. Amylase confirmed to be a useful marker in early detection of post-ERCP pancreatitis and is particularly effective in ruling out the complication with significant confidence, thus enabling early discharge of a significant proportion of patients. With the exception of IL-6 and to a lesser degree sE-selectin, which both appear to increase in patients with post-ERCP pancreatitis, the remaining biomolecules did not seem to change significantly at the early stages of post-ERCP pancreatitis or their change was not different between cases and controls (sP-selectin). Overall, no differences in the levels of the biomolecules studied were detected between cases and controls after ERCP.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2015
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Sigounas, Dimitrios
- Συγκούνας, Δημήτριος
Subjects
dc:subject × 18- Ενδοσκοπική παλίνδρομη χολαγγειοπαγκρεατογραφία
- Παγκρεατίτιδα
- Κυτταροκίνες
- Προσκολλητικά μόρια
- Κυτταρομετρία ροής
- Ενζυμο-ανοσολογική μέθοδος στερεάς φάσης
- Endoscopic retrograde cholangiopancreatography (ERCP)
- Pancreatitis
- Cytokines
- Adhesion molecules
- Flow cytometry
- Enzyme-linked immunosorbent assay (ELISA)
- Ιατρική και Επιστήμες Υγείας
- Βασική Ιατρική
- Κλινική Ιατρική
- Medical and Health Sciences
- Basic Medicine
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/43480